VolitionRx Limited announced that it has issued unsecured loan for gross proceeds of ?2.5 million on December 5, 2023. The unsecured loan bears interest at a rate of approximately 8% per year and has a stated maturity date of December 31, 2028. Subject to certain conditions, the loan can be drawn down in three tranches at Belgian Volition?s election on or prior to June 30, 2025, with ?1.5 million available immediately, ?0.5 million available from June 1, 2024 and the final ?0.5 million available from March 1, 2025.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7276 USD | -2.01% | -5.51% | +1.48% |
May. 14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.48% | 60.26M | |
-32.63% | 9.2B | |
-5.66% | 3.12B | |
-18.33% | 2.05B | |
-24.39% | 1.59B | |
+65.65% | 1.44B | |
+32.83% | 830M | |
-6.77% | 720M | |
-29.80% | 507M | |
+0.40% | 297M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- VolitionRx Limited announced that it has received ?2.5 million in funding